And it depends on you how soon it will be developed
Equities have greeted 2018 with a bang, but none more so than Korean pharmaceutical maker Celltrion Inc., which has piled on about 9 trillion won ($8.4 billion) of market value in just seven days.
On Wednesday, Warren Buffett's Berkshire Hathaway disclosed a $358 million stake in Israeli generic drug company Teva Pharmaceutical Industries.
Multi-resistent microbes are a growing danger. The often unnecessary and mass use of antibiotics causes the impassivity of pathogens against drugs. Infections that were easily curable up to now, may become life threatening.
In 2016, the United States spent nearly twice as much as 10 high-income countries on medical care and performed less well on many population health outcomes.